These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 7651452)

  • 1. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
    Pacchetti C; Albani G; Martignoni E; Godi L; Alfonsi E; Nappi G
    Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of post-hemiplegic painful dystonia following thalamic infarction with good response to botulinus toxin].
    Motoi Y; Hattori Y; Miwa H; Shina K; Mizuno Y
    Rinsho Shinkeigaku; 1997 Oct; 37(10):881-6. PubMed ID: 9490897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics of painful dystonic foot response in patients with Parkinson's disease].
    Hara H; Wakayama Y; Kawase J
    Rinsho Shinkeigaku; 1989 Sep; 29(9):1101-5. PubMed ID: 2598534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parkinsonian dystonia].
    Dowsey-Limousin P
    Rev Neurol (Paris); 2003 Oct; 159(10 Pt 1):928-31. PubMed ID: 14615683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin A injections for the treatment of hand tremors.
    Trosch RM; Pullman SL
    Mov Disord; 1994 Nov; 9(6):601-9. PubMed ID: 7845399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin A--injection for cervical dystonia.
    Bhaumik S; Behari M
    J Assoc Physicians India; 1999 Mar; 47(3):267-70. PubMed ID: 10999117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind trial of botulinum toxin for treatment of focal hand dystonia.
    Cole R; Hallett M; Cohen LG
    Mov Disord; 1995 Jul; 10(4):466-71. PubMed ID: 7565828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
    Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M
    Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of nonoccupational limb and trunk dystonia with botulinum toxin.
    Quirk JA; Sheean GL; Marsden CD; Lees AJ
    Mov Disord; 1996 Jul; 11(4):377-83. PubMed ID: 8813216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
    Marconi R; Lefebvre-Caparros D; Bonnet AM; Vidailhet M; Dubois B; Agid Y
    Mov Disord; 1994 Jan; 9(1):2-12. PubMed ID: 8139601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of distant effects of local injections of botulinum toxin.
    Garner CG; Straube A; Witt TN; Gasser T; Oertel WH
    Mov Disord; 1993; 8(1):33-7. PubMed ID: 8380486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensor truncal dystonia: successful treatment with botulinum toxin injections.
    Comella CL; Shannon KM; Jaglin J
    Mov Disord; 1998 May; 13(3):552-5. PubMed ID: 9613753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distant effects of local injection of botulinum toxin.
    Lange DJ; Brin MF; Warner CL; Fahn S; Lovelace RE
    Muscle Nerve; 1987; 10(6):552-5. PubMed ID: 3455658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
    Brin MF; Fahn S; Moskowitz C; Friedman A; Shale HM; Greene PE; Blitzer A; List T; Lange D; Lovelace RE
    Mov Disord; 1987; 2(4):237-54. PubMed ID: 3504553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to botulinum toxin F in seronegative botulinum toxin A--resistant patients.
    Greene PE; Fahn S
    Mov Disord; 1996 Mar; 11(2):181-4. PubMed ID: 8684389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
    Kanovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
    Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin in the treatment of dystonic tics.
    Jankovic J
    Mov Disord; 1994 May; 9(3):347-9. PubMed ID: 8041378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
    Sankhla C; Jankovic J; Duane D
    Mov Disord; 1998 Jan; 13(1):150-4. PubMed ID: 9452341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.